Symbol: MRK

Current USD Price: $0.00114740848899

Market Cap: $923,662

24 Hour Change: -0.91244633%

1 Hour Change: 0.30909302%

Back Home

Top 25 Currencies

Name Price 1H Change
GlobalBoost-Y $0.0557053030844 0.31800759%
RigoBlock $0.739496395021 2.74733798%
Wings $0.0998035591184 1.31723555%
Smart MFG $0.0331078532411 2.47259054%
Noah Coin $7.580681433E-5 0.78688112%
AnimalGo $0.0103217862099 -1.65733056%
Super Zero Protocol $0.315202971768 1.1164871%
Dusk Network $0.26896669946 -0.38968947%
BlueCoin $0.00172111273348 0.30909302%
FC Barcelona Fan Token $33.4922796569 -0.1932426%
APIX $0.0818950332575 -0.18694332%
Clash Token $0.664837577712 2.74733798%
Yield Stake Finance $8.88542334608 -0.13892486%
Wrapped Bitcoin $57753.3455159 1.09897452%
Atlas Protocol $0.00382923587967 3.0693634%
Privatix $0.0894978621827 -8.48995022%
DSLA Protocol $0.015280141375 1.38793228%
DFI.Money $2552.35444231 1.0029369%
Mettalex $8.7604480559 -0.86932316%
CWV Chain $0.00277780757175 0.09529617%
Infinitus Token $0.151086268391 0%
HyperQuant $0.00098047954229 1.06302524%
PLNcoin $0.00057370424449 0.30909302%
Garlicoin $0.154390788455 -0.33789596%
Venus USDC $0.0204575451804 -0.02655441%

Major Gainers In The Last Hour

Name Price 1H Change
AIDUS TOKEN $0.0129043805827 91.28785028%
The ChampCoin $0.00429838776657 9.97746343%
Satozhi $1.69363584191 9.77549469%
UniLayer $2.43155356045 9.7547406%
Coinsuper Ecosystem Network $0.00156123304734 9.65081652%

Major Gainers In The Last 24 Hour

Name Price 24H Change
Dopple Finance $1.65326337069 99.43744484%
wave edu coin $0.00114827718378 98.81961922%
Ixinium $0.354711102427 98.7884039%
Sad Cat Token $7.486938316E-5 98.37123091%
onLEXpa $0.0001147408489 98.17510733%

Latest MARK.SPACE News

Merck (MRK) Gains As Market Dips: What You Should Know - Yahoo Finance
Dow Jones Today Rides Commodities Rally To New High, Nasdaq Lags; Freeport Jumps, BioNTech Spikes On Asia Deal - Investor's Business Daily
Resources Investment Advisors, Inc. Buys ARK Innovation ETF, iShares Core S&P 500 ETF, SPDR Portfolio S&P 1500 Composite Stock Market ETF, Sells Lumentum Holdings Inc, PIMCO Enhanced Short Maturity Active Exchange-Trad, Hartford Multifactor Developed Mark -
Everything You Need To Know About MARK.SPACE - A Beginner?s Guide To MARK.SPACE Universe - Cointelegraph
The Zacks Analyst Blog Highlights: JPMorgan, Home Depot, Merck, T-Mobile US and Twilio - Nasdaq
April 2020 Portfolio Update - Higher And Higher - Seeking Alpha
Dow Jones Today Takes New High; Stocks Mixed As Jobless Claims Decline: PayPal Rallies; These 3 Blue Chips In Buy Zones - Investor's Business Daily
EPAM Beats Q1 Earnings & Revenue Estimates, Raises Outlook - Nasdaq
Merck (MRK) Molnupiravir Pill Could Change the Fight Against Covid - Bloomberg
Cypress Capital Management LLC (WY) Buys DCP Midstream LP, Southwest Airlines Co, SPDR Oil & Gas Exploration and Production ETF, Sells SPDR Semiconductors ETF, Teradyne Inc, Edwards Lifesciences Corp -
Cannell Peter B & Co Inc Buys -
Merck (MRK) is a Top Dividend Stock Right Now: Should You Buy? - Nasdaq
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom - Benzinga
Is Merck (MRK) A Good Stock To Buy Now? - Yahoo Finance
Merck (MRK) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Merck (MRK) Stock Sinks As Market Gains: What You Should Know - Yahoo Finance
Merck & Co. (MRK) Q4 2020 Earnings Call Transcript - Motley Fool
Merck (MRK) Gets Priority Tag for Pneumococcal Vaccine BLA - Yahoo Finance
Why Merck (MRK) is a Top Dividend Stock for Your Portfolio - Yahoo Finance
Stalin retains seasoned leaders, Cabinet to have 34 ministers - National Herald
Trump campaign paid Arizona state Rep. Mark Finchem $6,000 during effort to overturn election results - The Arizona Republic
Merck's (MRK) Heart Failure Drug Vericiguat Gets FDA Nod - Yahoo Finance
Why Merck Is Playing Catch-Up in the Coronavirus Vaccine Chase - The Wall Street Journal
Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir - Yahoo Finance
Merck (MRK) Dips More Than Broader Markets: What You Should Know - Yahoo Finance
Mark Cuban Unveils Plan To Build Dallas Factory For New Drug Company - Kaiser Health News
Why Merck (MRK) is Poised to Beat Earnings Estimates Again - Yahoo Finance
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates - Yahoo Finance
Pharma Stock Roundup: SNY/GSK & PFE COVID-19 Vaccine Update, MRK's Pandion Buyout - Yahoo Finance
Merck (MRK) to Help J&J Make COVID-19 Vaccine to Boost Supply - Yahoo Finance
Pharma Stock Roundup: FDA Nod to MRK, AZN, JNJ, GSK Drugs, LLY's New Antibody Deal - Yahoo Finance
Pharma Stock Roundup: JNJ, NVS Q4 Earnings, MRK & LLY's Coronavirus Updates - Yahoo Finance
Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates - Yahoo Finance
Mark Shields: A little compassion, please - Mountain Democrat
Pharma Stock Roundup: PFE, MRK Q4 Earnings, AZN, JNJ Coronavirus Vaccine Updates - Yahoo Finance
Here?s Why Merck Is A Better Pick Over Johnson & Johnson Stock - Forbes
DMK?s MK Stalin, Leader-in-Waiting for Decades, Wins Tamil Nadu - The Quint
10 Stocks Warren Buffett Is Buying (And 11 He's Selling) - Kiplinger's Personal Finance
Mike Nally to Leave Merck; Frank Clyburn to Lead All Merck Human Health - Business Wire
Merck Scraps Covid-19 Vaccine Candidates - The Wall Street Journal
Merck Scraps Covid-19 Vaccine Candidates  The Wall Street Journal
Global Collaborative Robot (Cobot) Market Projected to Grow at a Healthy CAGR of 43.56% by 2027 ? Brockville Observer - Brockville Observer
N4T Investigators: Recall petition launched against Rep. Mark Finchem - KVOA Tucson News
These Are Barron?s 10 Best Stocks to Buy Right Now for 2021 - Barron's
A Beaver Full Moon lunar eclipse occurs Monday. Here's what to expect. -
An Intrinsic Calculation For Merck & Co., Inc. (NYSE:MRK) Suggests It's 27% Undervalued - Yahoo Finance
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates - Benzinga
Merck spinoff Organon to acquire Alydia Health for up to $240M - Mass Device
Merck Cashes Out Direct Investment In Moderna After 600% Year-To-Date Stock Gain - Yahoo Finance
'Companies need to take a stand': Black executives urge fight on voting limits - Reuters
Avoid Merck Stock Until Shares Pull Back -
PAND Stock: Why Pandion Therapeutics Shares Have Skyrocketed Today - InvestorPlace
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates - Benzinga
Dow ends above 32,000 milestone for first time. Here's how it got there - MarketWatch
Merck KGaA v Merck Sharp & Dohme - The Pharma Letter
Merck, one of Big Pharma's biggest players, reveals its COVID-19 vaccine and therapy plans - Science Magazine
7 Stock Spinoffs to Watch in 2021 | Stock Market News | US News - U.S News & World Report Money
Jeweler Monica Rich Kosann On Modernizing The Locket Necklace And Becoming A Certified B Corporation - Forbes
This blockchain-based platform creates entire cities in virtual reality - TNW
Billionaire David Siegel?s Top 10 Stock Picks - Yahoo Finance
Merck KGaA to boost lipid supply to vaccine maker BioNTech - Yahoo Finance
Merck's Spinoff Promises Higher Dividends and Big Upside -
This Underperforming Biotech Is Ready to Beat the Market - Motley Fool
Merck Announces Two US Regulatory Milestones for KEYTRUDA® (pembrolizumab) in Triple-Negative Breast Cancer (TNBC) - Business Wire
Coronavirus Is Changing This Year's Memorial Day Tributes At Fort Logan And Other National Cemeteries - Colorado Public Radio
NVS: 4 Healthcare Stocks to Buy and Hold for the Long Term -
Merck CEO Kenneth Frazier: George Floyd 'could be me' - CNBC
Why Bellus Health Stock Tanked 69.2% Today - The Motley Fool
Dewpoint Therapeutics Taps Ex-Sanofi Executive Ameet Nathwani as CEO - Xconomy
Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma - Xconomy
Should Investors Be Worried About Merck's Keytruda? - Motley Fool
Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals - Xconomy
Merck to Announce Multiple Scientific Efforts to Combat COVID-19 - Business Wire
Why Investors Should Buy the Dip in MRK Stock -
Charts That Rule the World: A thinkorswim® Special Focus - The Ticker Tape
Mark Rober Youtube Channel - City Watch
MRK Partners buys senior affordable living facility in South Miami Heights - The Real Deal
Adimab Spinout Adagio Raises $50M for Coronavirus Antibody R&D - Xconomy
Merck's Keytruda Fails Pivotal Bladder Cancer Study, Sinks First-Line Hopes - Xconomy
Markarian 1216: Isolated Galaxy Has Dark Matter-Rich Core | Astronomy -
US STOCKS-Nasdaq scales new high ahead of big-tech earnings; cyclicals lag - Yahoo Finance
Extended emission filaments found in the galaxy Markarian 6 -
Generation Gap: Ranking each and every VW Golf GTI generation - Driving
It's Merck vs. Merck as name confusion, complicated by social media, leads to legal showdown - FiercePharma
Bio Roundup: A Telehealth Combo, FDA's BCMA OK, Biogen's Bet & More - Xconomy
New antiviral drug discovered at Emory offers hope for COVID-19 treatment - Emory News Center
Isolated for Billions of Years??A ?Dark Galaxy? Almost as Old as Universe Itself? - The Daily Galaxy --Great Discoveries Channel
Is Teva Pharmaceuticals Stock a Buy? - The Motley Fool
Merck Offers Accelerated One-Year Asset Appreciation (MRK) - Stock Investor
Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact - Xconomy
Ransomware Cost Surpasses $25 Million Mark - Fortune
Xilio Taps Former Tesaro Exec Martin Huber as Chief Medical Officer - Xconomy
County commissioners approve property use change for old MRK truck wash site - Lexington Clipper Herald
India Just Launched Its Largest Rocket Ever - Popular Mechanics
Early movers: MRK, GE, EXE, XRX, GOOGL, AAPL, FB & more - CNBC
The 12 Best Low-Volatility Stocks of the Market Crash - Kiplinger's Personal Finance
Merck's Keytruda Could Face Direct Competition from New Chinese Drug - The Motley Fool
Will the Trump-Frazier tiff set off a White House attack on drug prices? - STAT
Every Golf GTI ranked: from worst to best -
REAL ESTATE TRANSACTIONS: December 18 ? 22, 2017 - Martha's Vineyard Times
Merck Data Are Another Step for Immunotherapy in Breast Cancer - Xconomy